EODData

NASDAQ, MBIO:

26 Aug 2025
LAST:

1.510

CHANGE:
 0.03
OPEN:
1.570
HIGH:
1.600
ASK:
13.310
VOLUME:
166.9K
CHG(%):
1.95
PREV:
1.540
LOW:
1.500
BID:
12.550
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
26 Aug 251.5701.6001.5001.510166.9K
25 Aug 251.6501.6801.5301.540128.2K
22 Aug 251.7001.7601.5901.650176.7K
21 Aug 251.5801.6991.5801.69050.6K
20 Aug 251.6301.6801.5601.65066.1K
19 Aug 251.6701.7401.6001.640105.2K
18 Aug 251.7001.7661.6601.690108.3K
15 Aug 251.7801.7901.7081.770117.6K
14 Aug 251.8001.8361.6801.780117.1K
13 Aug 251.6801.8801.6801.870233.4K

COMPANY PROFILE

Name:
About:Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases. It develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-101, an IL13Ra2 CAR T cell program for glioblastoma; and MB-108 for the treatment of herpes simplex virus-1 oncolytic virus C134. The company was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:95 Sawyer Road, Waltham, MA, United States, 02453
Website:https://www.mustangbio.com
CUSIP:62818Q104
CIK:0001680048
ISIN:US62818Q1040
FIGI:BBG00FXTN420
LEI:5493004W0VC1DPECQ779

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:0.82
PtB:4.11
Shares:6.39M
Market Cap:9.66M

TECHNICAL INDICATORS

MA5:1.61
MA10:1.68
MA20:1.63
MA50:1.74
MA100:1.49
MA200:1.50
RSI14:52.04
WPR14:-100.00
MTM14:-0.01
ROC14:-0.01
ATR:0.16
Week High:1.76
Week Low:1.50
Month High:1.96
Month Low:1.40
Year High:7.00
Year Low:0.11

RECENT SPLITS

Date Ratio
16 Jan 20251-50
04 Apr 20231-15